Stable Isotope Labelled Xentuzumab Biosimilar – Anti-IGF1/IGF2 mAb – Research Grade

Reference: PX-TA1409-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Xentuzumab Biosimilar - Anti-IGF1/IGF2 mAb - Research Grade
SourceCAS 1417158-65-6
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsBI 836845
ReferencePX-TA1409-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-lambda
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Xentuzumab Biosimilar - Anti-IGF1/IGF2 mAb - Research Grade

General information on Anti-IGF1/IGF2 [Homo sapiens] (Xentuzumab) Monoclonal Antibody

Xentuzumab is investigated for the treatment of Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Xentuzumab Biosimilar – Anti-IGF1/IGF2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products